Nuvation Bio Inc. (NUVB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nuvation Bio Inc.

    NYSE: NUVB · Real-Time Price · USD
    3.88
    0.46 (13.45%)
    At close: Sep 05, 2025, 3:59 PM
    3.93
    1.15%
    After-hours: Sep 05, 2025, 07:57 PM EDT

    Nuvation Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 7.87M n/a n/a n/a
    Cost of Revenue
    		 7.08M n/a n/a n/a
    Gross Profit
    		 795K -222K -484K -368K
    Operating Income
    		 -592.63M -99.82M -119.73M -93.32M
    Interest Income
    		 27.06M 24.61M 7.45M 2.96M
    Pretax Income
    		 -567.94M -75.8M -104.2M -86.85M
    Net Income
    		 -567.94M -75.8M -104.2M -86.85M
    Selling & General & Admin
    		 69.23M 28.53M 31.92M 24.28M
    Research & Development
    		 99.12M 71.29M 87.81M 69.04M
    Other Expenses
    		 425.07M n/a -872K -644K
    Operating Expenses
    		 586.34M 99.82M 119.73M 93.32M
    Interest Expense
    		 341K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 593.42M 99.82M 119.73M 93.32M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 268.77M 218.88M 216.72M 197.89M
    Shares Outstanding (Diluted)
    		 268.77M 218.88M 216.72M 197.89M
    EPS (Basic)
    		 -2.11 -0.35 -0.48 -0.44
    EPS (Diluted)
    		 -2.11 -0.35 -0.48 -0.44
    EBITDA
    		 -566.91M -99.6M -119.53M -89.35M
    EBIT
    		 -567.6M -99.82M -119.73M -89.53M
    Depreciation & Amortization
    		 683K 222K 484K 368K

    Add to Watchlist